Javascript must be enabled to continue!
Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation
View through CrossRef
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia. We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels. We therefore hypothesize that the processes of angiogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and that PCSK6 plays a role in these processes.
Methods:
Association between SNPs near the
PCSK6
gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium. Associations of angiogenic factors with PCSK6 (transcriptomic and proteomic) and patient symptomatology were explored in a biobank of plaque endarterectomies (BiKE). Morpholino technology was used for
Pcsk6
knockdown in zebrafish, coupled with vascular phenotype studies.
Pcsk6-/-
mice were used to study the expression of vasculogenesis related genes and vascular morphology at baseline (12 weeks).
Results:
Rs7178801 and rs11639051 in the
PCSK6
gene were found to relate to plasma PDGFB and VEGFD levels. TGFB2, VEGFA, VEGFC, PDGFA and PLAUR associated with patients symptomatology in BiKE and correlated with PCSK6 levels. Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels along with cerebral and myocardial haemorrhage hemorrhage. Expression of angiogenic factors;
Vegfa, Vegfb, Angpt1
and
Tgfb2
were altered in the heart, liver and adipose tissue in
Pcsk6-/-
mice. Vessel density, length and branch numbers were reduced in the
Pcsk6
-/- compared to the controls in the superficial but more significantly in the deep peripheral vessels. The smooth muscle cell coverage of the retinal vasculature was also reduced in the
Pcsk6 -/-
mice vs controls and
Pdgfa
was significantly downregulated compared to controls in mouse retinas.
Conclusions:
PCSK6 associates with levels of angiogenic factors on the genetic, transcriptomic and proteomic level. Lack of
Pcsk6
in mice and zebrafish led to vascular patterning defects. Further planned studies will examine PCSK6 in pathological neovascularization.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 105: Proprotein Convertase Subtilisin/kexin Type 6 (Pcsk6) Plays A Role In Angiogenesis Regulation
Description:
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while surviving offspring have blindness and cyclopia.
We have shown that PCSK6 localizes to vascular smooth muscle cells of intra-plaque neovessels.
We therefore hypothesize that the processes of angiogenesis, atherosclerosis and plaque neovascularisation share common molecular regulators and that PCSK6 plays a role in these processes.
Methods:
Association between SNPs near the
PCSK6
gene and levels of 90 plasma proteins was tested using data from 30,931 individuals in the SCALLOP consortium.
Associations of angiogenic factors with PCSK6 (transcriptomic and proteomic) and patient symptomatology were explored in a biobank of plaque endarterectomies (BiKE).
Morpholino technology was used for
Pcsk6
knockdown in zebrafish, coupled with vascular phenotype studies.
Pcsk6-/-
mice were used to study the expression of vasculogenesis related genes and vascular morphology at baseline (12 weeks).
Results:
Rs7178801 and rs11639051 in the
PCSK6
gene were found to relate to plasma PDGFB and VEGFD levels.
TGFB2, VEGFA, VEGFC, PDGFA and PLAUR associated with patients symptomatology in BiKE and correlated with PCSK6 levels.
Gross phenotypic and histological examination of zebrafish embryos with ablated PCSK6 showed improper peripheral vascular patterning of intersegmental vessels along with cerebral and myocardial haemorrhage hemorrhage.
Expression of angiogenic factors;
Vegfa, Vegfb, Angpt1
and
Tgfb2
were altered in the heart, liver and adipose tissue in
Pcsk6-/-
mice.
Vessel density, length and branch numbers were reduced in the
Pcsk6
-/- compared to the controls in the superficial but more significantly in the deep peripheral vessels.
The smooth muscle cell coverage of the retinal vasculature was also reduced in the
Pcsk6 -/-
mice vs controls and
Pdgfa
was significantly downregulated compared to controls in mouse retinas.
Conclusions:
PCSK6 associates with levels of angiogenic factors on the genetic, transcriptomic and proteomic level.
Lack of
Pcsk6
in mice and zebrafish led to vascular patterning defects.
Further planned studies will examine PCSK6 in pathological neovascularization.
Related Results
Abstract MP02: Proprotein Convertase Subtilisin/kexin Type 6 (PCSK6) Is Involved In Regulation Of Vasculogenesis
Abstract MP02: Proprotein Convertase Subtilisin/kexin Type 6 (PCSK6) Is Involved In Regulation Of Vasculogenesis
Background:
PCSK6 cleaves and activates growth factors involved in cell differentiation and
Pcsk6-/-
mice exhibit 25% embryonic lethality, while...
Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia
Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia
Abstract
Aims
Familial hypercholesterolemia patients are characterized by early onset of coronary artery calcification and ather...
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein Convertase Subtilisin/Kexin 6 in Cardiovascular Biology and Disease
Proprotein convertase subtilisin/kexin 6 (PCSK6) is a secreted serine protease expressed in most major organs, where it cleaves a wide range of growth factors, signaling molecules,...
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
Directional and balancing selection on proprotein convertase subtilisin/kexin type 6 (PCSK6)
The selective pressures challenging the human population leave genetic signatures. This study was designed to detect positive and balancing selection on the proprotein convertase s...
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Selection of a Single Chain Variable Fragment Antibody (scFv) against Subtilisin BRC and its Interaction with Subtilisin BRC
Background:
The focus of this study was the selection of a single chain variable fragment
antibody (scFv) against subtilisin BRC, a fibrinolytic enzyme using phage display, and to...
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
PCSK9 Inhibitors: Pharmacology and Therapeutic Potential
Proprotein convertase subtilisin/Kexin type 9 (PCSK9) is a proteolytic enzyme that indirectly regulates serum LDL cholesterol by destroying LDL receptors. In clinical studies, the ...
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9
Abstract
Aims
Proprotein convertase subtilisin/kexin type-9 (PCSK9), a molecular determinant of low-density lipoprotein (LDL) re...
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech
Helobdella
Diversification of metazoan Kexin-like proprotein convertases: insights from the leech
Helobdella
Abstract
Intercellular communication is quintessential for multicellularity and often mediated by secreted peptide ligands. In Metazoa, proprotei...

